Bioventix (LON:BVXP) Hits New 1-Year Low – Here’s What Happened

Shares of Bioventix PLC (LON:BVXP) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as GBX 2,905 ($36.04) and last traded at GBX 2,998 ($37.19), with a volume of 7773 shares traded. The stock had previously closed at GBX 3,025 ($37.53).

Bioventix Stock Performance

The firm’s 50-day moving average is GBX 3,286.74 and its 200 day moving average is GBX 3,737.31. The firm has a market capitalization of £157.64 million, a P/E ratio of 1,852.76 and a beta of 0.35.

Insider Buying and Selling at Bioventix

In other news, insider Bruce Hiscock bought 24 shares of the company’s stock in a transaction dated Friday, November 22nd. The shares were bought at an average cost of GBX 3,822 ($47.41) per share, with a total value of £917.28 ($1,137.92). Company insiders own 8.02% of the company’s stock.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.